Author Correction: Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway (Nature Communications, (2021), 12, 1, (432), 10.1038/s41467-020-20664-5)

Sushil Kumar; Ajeya Nandi; Snahlata Singh; Rohan Regulapati; Ning Li; John W. Tobias; Christian W. Siebel; Mario Andres Blanco; Andres J. Klein-Szanto; Christopher Lengner; Alana L. Welm; Yibin Kang; Rumela Chakrabarti

doi:10.1038/s41467-022-30946-9

Author Correction: Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway (Nature Communications, (2021), 12, 1, (432), 10.1038/s41467-020-20664-5)

Sushil Kumar
, Ajeya Nandi
, Snahlata Singh
, Rohan Regulapati
, Ning Li
, John W. Tobias
, Christian W. Siebel
, Mario Andres Blanco
, Andres J. Klein-Szanto
, Christopher Lengner
, Alana L. Welm
, Yibin Kang
, Rumela Chakrabarti

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Abstract

The original version of this Article contained an error in Fig. 7. In Fig. 7a panels “alphaDll1” and “IMD” were inadvertently duplicated. The correct version of Fig. 7a is shown below.

Original language	English (US)
Article number	3927
Journal	Nature communications
Volume	13
Issue number	1
DOIs	https://doi.org/10.1038/s41467-022-30946-9
State	Published - Dec 2022

All Science Journal Classification (ASJC) codes

General Chemistry
General Biochemistry, Genetics and Molecular Biology
General Physics and Astronomy

Access to Document

10.1038/s41467-022-30946-9

Cite this

Kumar, S., Nandi, A., Singh, S., Regulapati, R., Li, N., Tobias, J. W., Siebel, C. W., Blanco, M. A., Klein-Szanto, A. J., Lengner, C., Welm, A. L., Kang, Y., & Chakrabarti, R. (2022). Author Correction: Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway (Nature Communications, (2021), 12, 1, (432), 10.1038/s41467-020-20664-5). Nature communications, 13(1), Article 3927. https://doi.org/10.1038/s41467-022-30946-9

@article{d9f7ba982a874fd3ae3107065c59ff71,

title = "Author Correction: Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway (Nature Communications, (2021), 12, 1, (432), 10.1038/s41467-020-20664-5)",

abstract = "The original version of this Article contained an error in Fig. 7. In Fig. 7a panels “alphaDll1” and “IMD” were inadvertently duplicated. The correct version of Fig. 7a is shown below.",

author = "Sushil Kumar and Ajeya Nandi and Snahlata Singh and Rohan Regulapati and Ning Li and Tobias, \{John W.\} and Siebel, \{Christian W.\} and Blanco, \{Mario Andres\} and Klein-Szanto, \{Andres J.\} and Christopher Lengner and Welm, \{Alana L.\} and Yibin Kang and Rumela Chakrabarti",

note = "Publisher Copyright: {\textcopyright} 2022, The Author(s).",

year = "2022",

month = dec,

doi = "10.1038/s41467-022-30946-9",

language = "English (US)",

volume = "13",

journal = "Nature communications",

issn = "2041-1723",

publisher = "Nature Research",

number = "1",

}

Kumar, S, Nandi, A, Singh, S, Regulapati, R, Li, N, Tobias, JW, Siebel, CW, Blanco, MA, Klein-Szanto, AJ, Lengner, C, Welm, AL, Kang, Y & Chakrabarti, R 2022, 'Author Correction: Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway (Nature Communications, (2021), 12, 1, (432), 10.1038/s41467-020-20664-5)', Nature communications, vol. 13, no. 1, 3927. https://doi.org/10.1038/s41467-022-30946-9

Author Correction: Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway (Nature Communications, (2021), 12, 1, (432), 10.1038/s41467-020-20664-5). / Kumar, Sushil; Nandi, Ajeya; Singh, Snahlata et al.
In: Nature communications, Vol. 13, No. 1, 3927, 12.2022.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Author Correction

T2 - Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway (Nature Communications, (2021), 12, 1, (432), 10.1038/s41467-020-20664-5)

AU - Kumar, Sushil

AU - Nandi, Ajeya

AU - Singh, Snahlata

AU - Regulapati, Rohan

AU - Li, Ning

AU - Tobias, John W.

AU - Siebel, Christian W.

AU - Blanco, Mario Andres

AU - Klein-Szanto, Andres J.

AU - Lengner, Christopher

AU - Welm, Alana L.

AU - Kang, Yibin

AU - Chakrabarti, Rumela

PY - 2022/12

Y1 - 2022/12

N2 - The original version of this Article contained an error in Fig. 7. In Fig. 7a panels “alphaDll1” and “IMD” were inadvertently duplicated. The correct version of Fig. 7a is shown below.

AB - The original version of this Article contained an error in Fig. 7. In Fig. 7a panels “alphaDll1” and “IMD” were inadvertently duplicated. The correct version of Fig. 7a is shown below.

UR - https://www.scopus.com/pages/publications/85133574263

UR - https://www.scopus.com/pages/publications/85133574263#tab=citedBy

U2 - 10.1038/s41467-022-30946-9

DO - 10.1038/s41467-022-30946-9

M3 - Comment/debate

C2 - 35798701

AN - SCOPUS:85133574263

SN - 2041-1723

VL - 13

JO - Nature communications

JF - Nature communications

IS - 1

M1 - 3927

ER -

Author Correction: Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway (Nature Communications, (2021), 12, 1, (432), 10.1038/s41467-020-20664-5)

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this